Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2013

Open Access 01-12-2013 | Research article

“Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study”

Authors: Jose Gregorio Soto-Campos, Vicente Plaza, Joan B Soriano, Carlos Cabrera-López, Carlos Almonacid-Sánchez, Rosa Vazquez-Oliva, Jose Serrano, Aitor Ballaz-Quincoces, Alicia Padilla-Galo, Vanessa Santos, Grupo Emergente de Asma (GEA) del Área de Asma de la SEPAR

Published in: BMC Pulmonary Medicine | Issue 1/2013

Login to get access

Abstract

Background

There is limited information on the causes of death in asthma patients.
To determine the causes of death in hospitalized asthmatic patients and to compare with those observed in COPD patients and non-respiratory individuals, with a particular interest in associations with previous cardiovascular disease.

Methods

Retrospective case–control study which analyzed the deaths of all hospitalized patients admitted for any reason during January, April, July and October of 2008 in 13 Spanish centers. Medical records of deceased patients were reviewed, and demographic and clinical data were collected.

Results

A total of 2,826 deaths (mean age 75 years, 56% men) were included in the analysis, of which 82 (2.9%) were of patients with asthma and 283 (10%) with COPD.
The most common causes of death in asthma patients were cardiovascular diseases (29.3%), malignancies (20.7%) and infections (14.6%); in COPD patients they were malignancies (26.5%), acute respiratory failure (25.8%) and cardiovascular diseases (21.6%). Asthma, compared to COPD patients, died significantly less frequently from acute respiratory failure and lung cancer. A multivariate logistic regression analysis failed to associate asthma with cardiovascular deaths.

Conclusions

Cardiovascular disease is the most frequent cause of death among hospitalized asthma patients. The specific causes of death differ between asthma and COPD patients.
Literature
1.
go back to reference Neffen H, Baena-Cagnani C, Malka S, Sole D, Sepúlveda R, Caraballo L, et al: Asthma mortality in Latin America. J Investig Allergol Clin Immunol. 1997, 7: 249-253.PubMed Neffen H, Baena-Cagnani C, Malka S, Sole D, Sepúlveda R, Caraballo L, et al: Asthma mortality in Latin America. J Investig Allergol Clin Immunol. 1997, 7: 249-253.PubMed
2.
go back to reference Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA, On the behalf of the Working Group of the Asthma Programme in Finland 1994–2004: Asthma programme in Finland: a community problem needs community solutions. Thorax. 2001, 56: 806-814. 10.1136/thorax.56.10.806.CrossRefPubMedPubMedCentral Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA, On the behalf of the Working Group of the Asthma Programme in Finland 1994–2004: Asthma programme in Finland: a community problem needs community solutions. Thorax. 2001, 56: 806-814. 10.1136/thorax.56.10.806.CrossRefPubMedPubMedCentral
3.
go back to reference Bellido-Casado J, Plaza V, Bardagí S, Cosano J, López Viña A, Martínez Moragón E, Rodríguez-Trigo G, Picado C, Sanchos J: Disminuye la incidencia de asma de riesgo vital en España?. Arch Bronconeumol. 2006, 42: 522-525.CrossRefPubMed Bellido-Casado J, Plaza V, Bardagí S, Cosano J, López Viña A, Martínez Moragón E, Rodríguez-Trigo G, Picado C, Sanchos J: Disminuye la incidencia de asma de riesgo vital en España?. Arch Bronconeumol. 2006, 42: 522-525.CrossRefPubMed
4.
go back to reference López-Campos JL, Cayuela A, Rodríguez-Dominguez S, Vigil E: Temporal trends in asthma mortality over 30 years. J Asthma. 2008, 45 (7): 611-614. 10.1080/02770900802127006.CrossRefPubMed López-Campos JL, Cayuela A, Rodríguez-Dominguez S, Vigil E: Temporal trends in asthma mortality over 30 years. J Asthma. 2008, 45 (7): 611-614. 10.1080/02770900802127006.CrossRefPubMed
5.
go back to reference Sáchez-Bahíllo M, García-Marcos M, Pérez_Fernández V, Martínez Torres AE, Sánchez Solís M: Evolución de la mortalidad por asma en España, 1960–2005. Arch Bronconeumol. 2009, 45 (3): 123-128. 10.1016/j.arbres.2008.05.004.CrossRef Sáchez-Bahíllo M, García-Marcos M, Pérez_Fernández V, Martínez Torres AE, Sánchez Solís M: Evolución de la mortalidad por asma en España, 1960–2005. Arch Bronconeumol. 2009, 45 (3): 123-128. 10.1016/j.arbres.2008.05.004.CrossRef
7.
go back to reference Guidelines for the Diagnosis and Management of Asthma. 2007, US Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication number 08–5846, http://www.nhlbi.nih.gov/guidelines, Guidelines for the Diagnosis and Management of Asthma. 2007, US Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication number 08–5846, http://​www.​nhlbi.​nih.​gov/​guidelines,
9.
go back to reference Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B: Low-dose inhaled corticosteroids and prevention of death from asthma. N Engl J Med. 2000, 343: 332-336. 10.1056/NEJM200008033430504.CrossRefPubMed Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B: Low-dose inhaled corticosteroids and prevention of death from asthma. N Engl J Med. 2000, 343: 332-336. 10.1056/NEJM200008033430504.CrossRefPubMed
10.
go back to reference Suissa S, Ernst P: Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001, 107: 937-944. 10.1067/mai.2001.115653.CrossRefPubMed Suissa S, Ernst P: Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001, 107: 937-944. 10.1067/mai.2001.115653.CrossRefPubMed
11.
go back to reference Murray CJ, López AD: Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997, 349: 1498-1504. 10.1016/S0140-6736(96)07492-2.CrossRefPubMed Murray CJ, López AD: Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997, 349: 1498-1504. 10.1016/S0140-6736(96)07492-2.CrossRefPubMed
12.
go back to reference Calverley PMA, Anderson JA, Celli BR, et al: Salmeterol and fluticasone propionate and survival in COPD. N Engl J Med. 2007, 356 (8): 775-789. 10.1056/NEJMoa063070.CrossRefPubMed Calverley PMA, Anderson JA, Celli BR, et al: Salmeterol and fluticasone propionate and survival in COPD. N Engl J Med. 2007, 356 (8): 775-789. 10.1056/NEJMoa063070.CrossRefPubMed
13.
go back to reference Anthonisen NR, Connett JE, Enright PL, Manfreda J, Lung Health Study Research group: Hospitalization and mortality in the lung health study. Am J Crit Care Med. 2002, 166: 333-339. 10.1164/rccm.2110093.CrossRef Anthonisen NR, Connett JE, Enright PL, Manfreda J, Lung Health Study Research group: Hospitalization and mortality in the lung health study. Am J Crit Care Med. 2002, 166: 333-339. 10.1164/rccm.2110093.CrossRef
14.
go back to reference Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B, BODE Collaborative Group: Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 186 (2): 155-161. 10.1164/rccm.201201-0034OC.CrossRefPubMed Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B, BODE Collaborative Group: Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 186 (2): 155-161. 10.1164/rccm.201201-0034OC.CrossRefPubMed
15.
go back to reference Sin DD, Anthonisen NR, Soriano JB, Agusti AG: Mortality in COPD: role of comorbidities. Eur Respir J. 2006, 28: 1245-1257. 10.1183/09031936.00133805.CrossRefPubMed Sin DD, Anthonisen NR, Soriano JB, Agusti AG: Mortality in COPD: role of comorbidities. Eur Respir J. 2006, 28: 1245-1257. 10.1183/09031936.00133805.CrossRefPubMed
16.
go back to reference Silverstein MD, Reed CE, O’Connell EJ, Melton LJ, O’Fallon WM, Yunginger JW: Longterm survival of a cohort of community residents of asthma. N Engl J Med. 1994, 331 (23): 1537-1541. 10.1056/NEJM199412083312301.CrossRefPubMed Silverstein MD, Reed CE, O’Connell EJ, Melton LJ, O’Fallon WM, Yunginger JW: Longterm survival of a cohort of community residents of asthma. N Engl J Med. 1994, 331 (23): 1537-1541. 10.1056/NEJM199412083312301.CrossRefPubMed
17.
go back to reference Camargo CA, Barr RG, Chen R, Speizer FE: Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest. 2008, 134 (3): 546-551. 10.1378/chest.07-3126.CrossRefPubMedPubMedCentral Camargo CA, Barr RG, Chen R, Speizer FE: Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest. 2008, 134 (3): 546-551. 10.1378/chest.07-3126.CrossRefPubMedPubMedCentral
18.
go back to reference Jørgensen IM, Jensen VB, Bülow S, Dahm TL, Prahl P, Juel K: Asthma mortality in the Danish child population: risk factors and causes of asthma death. Pediatr Pulmonol. 2003, 36 (2): 142-147. 10.1002/ppul.10305.CrossRefPubMed Jørgensen IM, Jensen VB, Bülow S, Dahm TL, Prahl P, Juel K: Asthma mortality in the Danish child population: risk factors and causes of asthma death. Pediatr Pulmonol. 2003, 36 (2): 142-147. 10.1002/ppul.10305.CrossRefPubMed
19.
go back to reference De Marco R, Locatelli F, Cazzoletti L, Bugianio M, Carosso A, Marinoni A: Incidence of asthma and mortality in a cohort of young adults: a 7-year prospective study. Respir Res. 2005, 6: 95-104. 10.1186/1465-9921-6-95.CrossRefPubMedPubMedCentral De Marco R, Locatelli F, Cazzoletti L, Bugianio M, Carosso A, Marinoni A: Incidence of asthma and mortality in a cohort of young adults: a 7-year prospective study. Respir Res. 2005, 6: 95-104. 10.1186/1465-9921-6-95.CrossRefPubMedPubMedCentral
20.
go back to reference Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL: Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005, 128: 2099-2107. 10.1378/chest.128.4.2099.CrossRefPubMed Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL: Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005, 128: 2099-2107. 10.1378/chest.128.4.2099.CrossRefPubMed
21.
go back to reference Thomas M, Price D: Impact of comorbidities on asthma. Expert Rev Clin Immunol. 2008, 4 (6): 731-742. 10.1586/1744666X.4.6.731.CrossRefPubMed Thomas M, Price D: Impact of comorbidities on asthma. Expert Rev Clin Immunol. 2008, 4 (6): 731-742. 10.1586/1744666X.4.6.731.CrossRefPubMed
22.
go back to reference Boulet LP: Influence of comorbid conditions on asthma. Eur Respir J. 2009, 33 (4): 897-906. 10.1183/09031936.00121308.CrossRefPubMed Boulet LP: Influence of comorbid conditions on asthma. Eur Respir J. 2009, 33 (4): 897-906. 10.1183/09031936.00121308.CrossRefPubMed
23.
go back to reference de Llano LA P, González FC, Añón OC, Perea MP, Caruncho MV, Villar AB: Relationship between comorbidity and asthma control. Arch Bronconeumol. 2010, 46 (10): 508-513. de Llano LA P, González FC, Añón OC, Perea MP, Caruncho MV, Villar AB: Relationship between comorbidity and asthma control. Arch Bronconeumol. 2010, 46 (10): 508-513.
24.
go back to reference Sin DD, Man SF: Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005, 2 (1): 8-11. 10.1513/pats.200404-032MS.CrossRefPubMed Sin DD, Man SF: Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005, 2 (1): 8-11. 10.1513/pats.200404-032MS.CrossRefPubMed
25.
go back to reference Onufrak S, Abramson J, Austin H, Holguin F, McClellan W, Viola Vaccarino L: Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol. 2008, 101 (9): 1247-1252. 10.1016/j.amjcard.2007.12.024.CrossRefPubMedPubMedCentral Onufrak S, Abramson J, Austin H, Holguin F, McClellan W, Viola Vaccarino L: Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol. 2008, 101 (9): 1247-1252. 10.1016/j.amjcard.2007.12.024.CrossRefPubMedPubMedCentral
26.
go back to reference Dogra S, Adern CI, Baker J: The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma. 2007, 44 (10): 849-854. 10.1080/02770900701752391.CrossRefPubMed Dogra S, Adern CI, Baker J: The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma. 2007, 44 (10): 849-854. 10.1080/02770900701752391.CrossRefPubMed
27.
go back to reference Schanen JG, Iribarren C, Shanar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR: Asthma and incident cardiovascular disease: the atherosclerosis risk in communities study. Thorax. 2005, 60: 633-638. 10.1136/thx.2004.026484.CrossRefPubMedPubMedCentral Schanen JG, Iribarren C, Shanar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR: Asthma and incident cardiovascular disease: the atherosclerosis risk in communities study. Thorax. 2005, 60: 633-638. 10.1136/thx.2004.026484.CrossRefPubMedPubMedCentral
28.
go back to reference Jiménez-Puente A, Perea-Milla E, Rivas-Ruiz F: Distribution and trend of deaths within the hospital environment in Spain during the 1997–2003 period. Rev Esp Salud Publica. 2006, 80: 377-385.CrossRefPubMed Jiménez-Puente A, Perea-Milla E, Rivas-Ruiz F: Distribution and trend of deaths within the hospital environment in Spain during the 1997–2003 period. Rev Esp Salud Publica. 2006, 80: 377-385.CrossRefPubMed
30.
go back to reference Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E: Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008, 300 (20): 2407-2416. 10.1001/jama.2008.717.CrossRefPubMedPubMedCentral Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E: Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008, 300 (20): 2407-2416. 10.1001/jama.2008.717.CrossRefPubMedPubMedCentral
31.
go back to reference Singanayagam A, Chalmers JD, Akram AR, Hill AT: Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia. Eur Respir J. 2011, 38: 36-41. 10.1183/09031936.00077010.CrossRefPubMed Singanayagam A, Chalmers JD, Akram AR, Hill AT: Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia. Eur Respir J. 2011, 38: 36-41. 10.1183/09031936.00077010.CrossRefPubMed
32.
go back to reference O’Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S: Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med. 2011, 183 (5): 589-595. 10.1164/rccm.201005-0694OC.CrossRefPubMed O’Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S: Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med. 2011, 183 (5): 589-595. 10.1164/rccm.201005-0694OC.CrossRefPubMed
33.
go back to reference Adams RJ, Wilson DH, Taylor AW, Daly A, D´Espaignet ET, Grande ED, Ruffin RE: Coexistent chronic conditions and asthma quality of life: a population-based study. Chest. 2006, 129: 285-291. 10.1378/chest.129.2.285.CrossRefPubMed Adams RJ, Wilson DH, Taylor AW, Daly A, D´Espaignet ET, Grande ED, Ruffin RE: Coexistent chronic conditions and asthma quality of life: a population-based study. Chest. 2006, 129: 285-291. 10.1378/chest.129.2.285.CrossRefPubMed
34.
go back to reference Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R: Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax. 2010, 65: 39-43. 10.1136/thx.2009.116608.CrossRefPubMed Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R: Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax. 2010, 65: 39-43. 10.1136/thx.2009.116608.CrossRefPubMed
35.
go back to reference Oian FH, Zhang Q, Zhou LF, Liu H, Huang H, Zhang XL, Yin KS: High sensitivity creactive protein: a predictive marker in severe asthma. Respirology. 2008, 13 (5): 664-669. 10.1111/j.1440-1843.2008.01314.x.CrossRef Oian FH, Zhang Q, Zhou LF, Liu H, Huang H, Zhang XL, Yin KS: High sensitivity creactive protein: a predictive marker in severe asthma. Respirology. 2008, 13 (5): 664-669. 10.1111/j.1440-1843.2008.01314.x.CrossRef
36.
go back to reference Kasayama S, Tanemura M, Koya M, Fujita K, Yamamoto H, Miyatake A: Asthma is a independent risk for elevation of plasma C-reactive protein levels. Clin Chim Acta. 2009, 399 (1–2): 79-82.CrossRefPubMed Kasayama S, Tanemura M, Koya M, Fujita K, Yamamoto H, Miyatake A: Asthma is a independent risk for elevation of plasma C-reactive protein levels. Clin Chim Acta. 2009, 399 (1–2): 79-82.CrossRefPubMed
37.
go back to reference Siafakas NM, Antoniou KM, Tzortzaki EG: Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007, 2 (4): 453-462.PubMedPubMedCentral Siafakas NM, Antoniou KM, Tzortzaki EG: Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007, 2 (4): 453-462.PubMedPubMedCentral
38.
go back to reference Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE: Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res Rev. 2007, 27 (4): 469-527. 10.1002/med.20071.CrossRefPubMed Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE: Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res Rev. 2007, 27 (4): 469-527. 10.1002/med.20071.CrossRefPubMed
39.
go back to reference Peter-Golden M, Henderson WR: Leukotrienes. Mechanisms of disease. N Engl J Med. 2007, 357: 1841-1854. 10.1056/NEJMra071371.CrossRef Peter-Golden M, Henderson WR: Leukotrienes. Mechanisms of disease. N Engl J Med. 2007, 357: 1841-1854. 10.1056/NEJMra071371.CrossRef
40.
go back to reference Ingelssson E, Yin L, Bäck M: Nationwide cohort study of the leukotriene receptor antogonists montelukast and inicident or recurrent cardiovascular disease. J Allergy Clin Immunol. 2012, 129 (3): 702-707. 10.1016/j.jaci.2011.11.052.CrossRef Ingelssson E, Yin L, Bäck M: Nationwide cohort study of the leukotriene receptor antogonists montelukast and inicident or recurrent cardiovascular disease. J Allergy Clin Immunol. 2012, 129 (3): 702-707. 10.1016/j.jaci.2011.11.052.CrossRef
41.
go back to reference Beuther DA, Sutherland ER: Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care. 2001, 175: 661-666.CrossRef Beuther DA, Sutherland ER: Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care. 2001, 175: 661-666.CrossRef
42.
go back to reference Prosser R, Pharm C, Smith A: The comorbidity burden of treated asthma patient population in British Columbia. Chronic Dis Can. 2010, 30: 46-55.PubMed Prosser R, Pharm C, Smith A: The comorbidity burden of treated asthma patient population in British Columbia. Chronic Dis Can. 2010, 30: 46-55.PubMed
Metadata
Title
“Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study”
Authors
Jose Gregorio Soto-Campos
Vicente Plaza
Joan B Soriano
Carlos Cabrera-López
Carlos Almonacid-Sánchez
Rosa Vazquez-Oliva
Jose Serrano
Aitor Ballaz-Quincoces
Alicia Padilla-Galo
Vanessa Santos
Grupo Emergente de Asma (GEA) del Área de Asma de la SEPAR
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2013
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-13-73

Other articles of this Issue 1/2013

BMC Pulmonary Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.